HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ye Yuan Selected Research

Peptides (Polypeptides)

1/2019A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ1-42 aggregation.
1/2014Adeno-associated virus-mediated expression of recombinant CBD-HepII polypeptide of human fibronectin inhibits metastasis of breast cancer.
7/2012Targeting nuclear factor-κB suppresses the negative effect of toll-like receptor 4 signaling on antimetastasis therapy based on targeting αvβ3.
7/2007Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin.
7/2005[Inhibitory effect of 4-1BBL combined with Hsp70-tumor antigen peptides on pulmonary metastasis of melanoma in mice].
9/2004[Eukaryotic expression and functional characterization of PD-1 extracellular domain].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ye Yuan Research Topics

Disease

97Neoplasms (Cancer)
04/2022 - 01/2004
18Inflammation (Inflammations)
07/2022 - 08/2014
16Neoplasm Metastasis (Metastasis)
12/2022 - 07/2005
10Prostatic Neoplasms (Prostate Cancer)
04/2022 - 01/2019
10Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 06/2014
8Osteoporosis
01/2021 - 01/2017
8Infections
04/2020 - 05/2007
6Glioblastoma (Glioblastoma Multiforme)
12/2021 - 01/2018
5Parkinson Disease (Parkinson's Disease)
07/2022 - 05/2015
5Carcinoma (Carcinomatosis)
01/2022 - 01/2010
5Lung Neoplasms (Lung Cancer)
01/2022 - 03/2015
5Osteosarcoma (Osteogenic Sarcoma)
11/2021 - 07/2013
5Myocardial Infarction
03/2020 - 01/2018
5Glioma (Gliomas)
01/2020 - 01/2018
5Melanoma (Melanoma, Malignant)
01/2014 - 07/2005
4Disease Progression
11/2022 - 06/2014
4Body Weight (Weight, Body)
08/2022 - 12/2010
4Obesity
08/2022 - 04/2017
4Shock
12/2021 - 07/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2017
4Atherosclerosis
01/2021 - 08/2011
4Insulin Resistance
04/2020 - 08/2014
4Iron Overload
01/2020 - 05/2017
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 12/2003
4Carcinogenesis
01/2019 - 05/2007
4Ovarian Neoplasms (Ovarian Cancer)
02/2012 - 07/2005
3Pain (Aches)
01/2021 - 06/2016
3Cognitive Dysfunction
01/2021 - 12/2016
3COVID-19
01/2021 - 01/2020
3Ischemic Stroke
01/2021 - 12/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 05/2008
3Lymphoma (Lymphomas)
01/2021 - 12/2003
3Fever (Fevers)
12/2020 - 11/2011
3Wounds and Injuries (Trauma)
05/2020 - 12/2019
3Pathologic Constriction (Stenosis)
04/2020 - 08/2011
3Hodgkin Disease (Hodgkin's Disease)
03/2020 - 06/2017
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 08/2012
3Paralysis (Palsy)
08/2019 - 10/2018
3Asthma (Bronchial Asthma)
11/2017 - 01/2013
3Necrosis
05/2017 - 10/2008
3Cerebral Infarction
01/2017 - 11/2013
3Ischemia
01/2016 - 11/2013
3Hepatocellular Carcinoma (Hepatoma)
09/2005 - 01/2004

Drug/Important Bio-Agent (IBA)

22Pharmaceutical PreparationsIBA
01/2022 - 01/2012
19Proteins (Proteins, Gene)FDA Link
07/2021 - 07/2005
13MicroRNAs (MicroRNA)IBA
01/2021 - 08/2012
12Biomarkers (Surrogate Marker)IBA
04/2022 - 10/2008
10Messenger RNA (mRNA)IBA
11/2021 - 01/2004
10LigandsIBA
01/2021 - 10/2004
8Therapeutic UsesIBA
04/2022 - 08/2008
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 06/2014
7Biological ProductsIBA
12/2022 - 05/2007
7LipidsIBA
08/2022 - 08/2014
7Long Noncoding RNAIBA
01/2022 - 08/2018
6Phosphotransferases (Kinase)IBA
02/2022 - 06/2014
6Peptides (Polypeptides)IBA
01/2019 - 09/2004
5AntigensIBA
09/2022 - 01/2004
5EnzymesIBA
08/2022 - 06/2008
5Polysaccharides (Glycans)IBA
08/2022 - 11/2016
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
5DNA (Deoxyribonucleic Acid)IBA
07/2021 - 06/2006
5CytokinesIBA
01/2021 - 06/2006
5Fibronectins (Fibronectin)IBA
03/2016 - 07/2007
4Neuroprotective AgentsIBA
01/2022 - 08/2014
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 10/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 02/2012
4Small Interfering RNA (siRNA)IBA
11/2021 - 11/2013
4Nucleic AcidsIBA
07/2021 - 12/2018
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2007
4Glucose (Dextrose)FDA LinkGeneric
04/2020 - 08/2014
4MelatoninIBA
03/2020 - 05/2017
4NF-kappa B (NF-kB)IBA
01/2015 - 05/2007
3Transcription Factors (Transcription Factor)IBA
08/2022 - 01/2018
3Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 05/2007
3CopperIBA
01/2022 - 10/2008
36-methyladenineIBA
12/2021 - 03/2020
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2021 - 02/2012
3Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 08/2010
3Silicon Dioxide (Silica)FDA LinkGeneric
12/2020 - 01/2020
3PolymersIBA
12/2020 - 11/2017
3Glutathione (Reduced Glutathione)IBA
12/2020 - 09/2014
3IronIBA
10/2020 - 01/2018
3Caspase 3 (Caspase-3)IBA
01/2019 - 11/2013
3IntegrinsIBA
03/2016 - 06/2012
3VaccinesIBA
09/2013 - 01/2004
3Toll-Like Receptor 4IBA
07/2012 - 03/2012
2AutoantibodiesIBA
09/2022 - 12/2018
2banlangenIBA
08/2022 - 02/2019
2Adenosine (Adenocard)FDA LinkGeneric
08/2022 - 08/2008
2AntioxidantsIBA
08/2022 - 05/2017
2Cholecystokinin (Pancreozymin)IBA
07/2022 - 01/2022

Therapy/Procedure

39Therapeutics
03/2022 - 06/2006
13Drug Therapy (Chemotherapy)
02/2022 - 07/2005
11Radiotherapy
01/2021 - 01/2013
7Immunotherapy
06/2020 - 10/2004
3Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2020 - 06/2009
3Stents
05/2020 - 11/2013
3Precision Medicine
01/2019 - 11/2017
2Aftercare (After-Treatment)
11/2022 - 10/2018